Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

Hippocalcin

Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_251

Synonyms

 BDR2

Historical Background

Hippocalcin was originally cloned from a rat brain cDNA library based on the partial amino acid sequences from a calcium-binding protein with a molecular mass of 23,000 Da (P23k), which was purified during a survey of recoverin-like immunoreactivity in the brain (Kobayashi et al. 1992). During the 1990s, a number of calcium-binding proteins structurally related to hippocalcin were identified in the nervous system and named NCS (neuronal calcium sensor) proteins. There are 14 protein-coding genes in the NCS family in the human genome (Burgoyne 2007). Hippocalcin is a highly conserved protein and has an identical amino acid sequence in rat, mouse, bovine, and human (Kobayashi and Takamatsu 2009).

Protein Chemical Characteristics

Hippocalcin, a 23 kDa protein of 193 amino acid residues containing 10 α-helices and 2 antiparallel β-sheets, has three functional EF-hand calcium-binding domains and an N-terminal glycine residue covalently linked to myristic acid (Kobayashi and Takamatsu 2009; Li and Ames 2014). In hippocampal pyramidal cells, hippocalcin is located in the cytoplasm and associated with the plasma membrane of the cell body, dendrites, and axon. The hippocalcin concentration in hippocampal pyramidal cells is estimated to be higher than 30 μM. Calcium binding to the EF-hands of hippocalcin induces a conformational change that results in exposure of the myristoyl group and association of hippocalcin with the cellular membranes in response to free calcium in the 200–800 nM range. This process is referred to as a calcium myristoyl switch and is a prominent characteristic of some members of the NCS family, including recoverin, VILIP1, VILIP2, and VILIP3 (Burgoyne 2007). Hippocalcin reversibly translocates from the cytosol to the plasma membrane and the trans-Golgi network of the perinuclear region in transfected HeLa cells and in hippocampal cells via the calcium myristoyl switch mechanism (Kobayashi and Takamatsu 2009). The maximal rate of translocation to the membrane is approximately 1 s. Half-maximal translocation occurred at approximately 300 nM free calcium. In hippocampal neurons, spontaneous and action potential-dependent translocation of hippocalcin-YFP fluorescence was observed in different parts of neuronal processes, reaching peak translocation within 1–5 s (Markova et al. 2008). Local α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)-type glutamate receptor activation resulted in fast hippocalcin-YFP translocation to specific sites within a dendritic tree, and short local N-methyl-D-aspartate (NMDA) receptor activation induced fast hippocalcin-YFP translocation in a dendritic shaft at the application site, indicating that hippocalcin may differentially decode various spatiotemporal patterns of glutamate receptor activation into site- and time-specific translocation to its targets (Dovgan et al. 2010).

These results suggest that hippocalcin would be able to interact with target proteins on membranes when free calcium levels are only slightly elevated above resting levels. N-myristoylated hippocalcin, as well as an N-myristoylated hippocalcin peptide (1–14), interacts with liposomes containing phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) with high affinity (Kd = 50 nM) in a Ca2+-dependent manner (O’Callaghan et al. 2005). Expression of hippocalcin (1–14)-ECFP (enhanced cyan fluorescent protein) partially displaced the pleckstrin homology domain of phospholipase δ1, a PtdIns(4,5)P2-specific binding partner, from the plasma membrane in living cells. These results suggest that the interaction with PtdIns(4,5)P2 is likely to be a physiologically important event contributing to the targeting of hippocalcin.

Distribution

Hippocalcin is expressed in various regions of the rat hippocampus, as well as other regions of the brain (Kobayashi et al. 1992; Kobayashi and Takamatsu 2009). In the hippocampus, hippocalcin mRNA and immunoreactivity are detected at high levels in the pyramidal cells of Ammon’s horn and at moderate levels in the granule cells of the dentate gyrus. Hippocalcin is also found at high levels in other regions of the brain, including the pyramidal cells of cerebral cortex layers II–VI and the caudate-putamen, taenia tecti, claustrum, olfactory tubercle, anterior olfactory nucleus, and olfactory bulb, as well as in the ganglion cell layer and amacrine cell layer in the retina and in the apical layer in the olfactory epithelium. No hippocalcin protein expression has been detected outside of the central nervous system, although expressed sequence tag sequences have been found in a few peripheral tissues (Kobayashi and Takamatsu 2009).

Physiological Functions

Roles in Neural Plasticity

The hippocampus is an important cortical region for associative learning and memory and is especially important in the performance of spatial positioning discrimination. Hippocalcin may be involved in these functions. Hippocalcin-deficient (hippocalcin−/−) mice displayed deficits in spatial memory and working (trial-dependent) associative memory (Kobayashi et al. 2005). Hippocalcin may be involved in memory formation via regulation of the extracellular signal-regulated kinase (ERK) cascade. In hippocalcin−/− mice, NMDA stimulation- and depolarization-induced phosphorylation of cAMP response element-binding protein (CREB) was attenuated in hippocampal neurons (Kobayashi et al. 2005). Impaired CREB activation may be caused by a malfunctioning ERK cascade because an ERK cascade inhibitor blocked stimulation-dependent CREB phosphorylation in control hippocampal slices but not in hippocalcin−/− mice. When the Ca2+-dependent Ras/Raf/MEK/ERK signaling cascade was further examined, no direct effect of hippocalcin on Raf-1 kinase or MEK kinase was observed (Kobayashi and Takamatsu 2009). Hippocalcin also had no effect on the activation of Ras. However, hippocalcin−/− mice display a defect in NMDA- and depolarization-induced activation of Raf-1 kinase and ERK. Therefore, hippocalcin may act on an alternative Raf-1 kinase activation pathway, such as protein kinase B/Akt or 14-3-3 protein activation of Raf-1. Notably, hippocalcin, in conjunction with the small GTPase Cdc42, led to an increase in calcium-dependent phospholipase D activation. In NIH3T3 cells, phospholipase D activation induced by overexpression of hippocalcin was dependent on upregulation of phospholipase D expression via activation of the ERK cascade (Oh et al. 2006). These results indicate that hippocalcin affects activity-dependent gene expression via regulation of MAP kinase signaling (see Fig. 1).
Hippocalcin, Fig. 1

Involvement of hippocalcin in neuronal excitability. AC adenylyl cyclase, PLC phospholipase C, PKC protein kinase C, G protein guanine nucleotide-binding protein, β2 β2-adaptin subunit of the AP2 adaptor complex, ERK extracellular signal-regulated kinase, CREB cAMP response element-binding protein, AMPA α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid

Moreover, hippocalcin has been implicated in hippocampal NMDA receptor-dependent long-term depression (LTD) (Palmer et al. 2005; Fig. 1). Hippocalcin binds directly to the β2-adaptin subunit of the AP2 adaptor complex, which couples clathrin to the cytosolic domains of membrane-bound proteins destined to be internalized. In hippocampal neurons, this hippocalcin-AP2 complex bound only to the GluR1 subunit of the AMPA receptor. The calcium-dependent endocytosis of the AMPA receptor is a key event in NMDA receptor-dependent LTD. Expression of a mutated hippocalcin lacking all EF-hand structures in CA1 pyramidal neurons blocked synaptically evoked LTD without affecting basal AMPA receptor-mediated transmission or long-term potentiation.

In addition, hippocalcin is the key intermediate between calcium influx in response to a train of action potentials and potassium channel activation, which mediates the slow after-hyperpolarization current (IsAHP) in hippocampal neurons (Tzingounis et al. 2007; Fig. 1). Brief depolarizations, which are sufficient to activate IsAHP in wild-type mice, did not elicit IsAHP in hippocalcin−/− mice. Introduction of hippocalcin into cultured rat hippocampal neurons led to a pronounced IsAHP, while neurons expressing a mutant hippocalcin lacking N-terminal myristoylation exhibited a small IsAHP similar to that recorded in uninfected neurons, confirming that hippocalcin gates the potassium channel that mediates IsAHP (IsAHP channel). Application of a KCNQ-type potassium channel activator accelerates the rise of IsAHP, indicating that slow after-hyperpolarization (sAHP) activation is critically dependent on KCNQ channel kinetics. The decay of sAHP is prolonged in hippocalcin−/− mice, suggesting that hippocalcin determines the composition of the IsAHP channels. The role of hippocalcin in activation of the IsAHP channel is mediated by the generation of PtdIns(4,5)P2 (Kim et al. 2016).

Protection Against Neuronal Damage

Hippocalcin was shown to have neuroprotective effects in several studies (see Fig. 2). Hippocalcin interacts with neuronal apoptosis inhibitory protein (NAIP). Overexpression of hippocalcin alone did not substantially enhance cell survival, but co-expression of both hippocalcin and NAIP synergistically facilitates neuronal survival against calcium-induced cell death stimuli, such as ionomycin and thapsigargin. The interaction between hippocalcin and NAIP rescues neuroblastoma cells from calcium-induced cell death, but no significant effect on neuronal death induced by nerve growth factor (NGF) withdrawal has been observed in sympathetic neurons (Lindholm et al. 2002). In hippocalcin−/− mice, systemic injection of kainic acid results in an increase in seizure-induced neuronal cell death in the CA3 field of Ammon’s horn accompanied by increased caspase-3 activation (Kobayashi and Takamatsu 2009). Injection of quinolinic acid, an NMDA receptor agonist, into the hippocampal CA1 region of hippocalcin−/− mice caused high levels of cell death in CA1 neurons. Cultured hippocalcin−/− hippocampal neurons exhibited reduced levels of survival under basal culture conditions accompanied by an increase in caspase 12 activation, which can be caused by increased endoplasmic reticulum (ER) stress (Kobayashi and Takamatsu 2009). A decrease in the survival rate of hippocalcin−/− hippocampal neurons was also observed independently, in a study in which the measurement of intracellular calcium in single cells revealed that calcium extrusion from hippocalcin−/− neurons was slower than that from wild-type neurons (Kobayashi and Takamatsu 2009). The involvement of hippocalcin in the upregulation of calcium extrusion was confirmed using hippocalcin-expressing COS7 cells. Thus, hippocalcin protects hippocampal neurons against various types of calcium-induced cell damage by interacting with NAIP, diminishing ER stress, and upregulating calcium extrusion (Fig. 2).
Hippocalcin, Fig. 2

Involvement of hippocalcin in the neuronal apoptosis induction pathway. NAIP neuronal apoptosis inhibitory protein, ER endoplasmic reticulum

Roles in Energy Shuttle

Hippocalcin specifically binds to the creatine kinase B (CKB) subunit, which constitutes brain-type creatine kinase (BB-CK), in a calcium-dependent manner (Kobayashi et al. 2012). Hippocalcin mediates calcium-dependent partial translocation of CKB to membranes. N-myristoylation of hippocalcin is critical for membrane translocation but not for binding to CKB. In cultured hippocampal neurons, ionomycin treatment leads to colocalization of hippocalcin and CKB adjacent to the plasma membrane. These results indicate that hippocalcin associates with BB-CK and that together they translocate to membrane compartments in a calcium-dependent manner.

Roles in Olfactory Signaling

Hippocalcin modulates adenylyl cyclase and guanylyl cyclase activities in the olfactory epithelium where cilia of mature olfactory receptor neurons reside (see Fig. 3). In the olfactory cilia, odorant-induced activation of adenylyl cyclase and guanylyl cyclase results in generation of cAMP and cGMP, respectively. As the levels of cyclic nucleotides increase, olfactory cyclic nucleotide-gated channels open to allow an influx of sodium and calcium ions, leading to the generation of an action potential. Hippocalcin increased adenylyl cyclase activity in olfactory cilia at low calcium levels and decreased adenylyl cyclase activity at high calcium levels in a reconstitution system (Mammen et al. 2004). At low calcium levels, protein kinase treatment of cilia inhibited the effect of hippocalcin on adenylyl cyclase activity, whereas untreated cilia or protein phosphatase-treated cilia showed increases in hippocalcin-mediated adenylyl cyclase activity. At high calcium levels, only protein phosphatase-treated cilia showed significant increases in hippocalcin-mediated adenylyl cyclase activity. Calcium influx by odorant stimulation induces phosphorylation of adenylyl cyclase, which may reduce adenylyl cyclase activity and be involved in the mechanisms of odorant adaptation. In contrast to the effect on adenylyl cyclase, hippocalcin significantly inhibited the activity of particulate guanylyl cyclase within a limited range of free calcium concentrations (1–10 nM) (Mammen et al. 2004). The inhibitory effect of hippocalcin on guanylyl cyclase activity decreased as calcium levels increased. At physiological levels of calcium, hippocalcin increased guanylyl cyclase activity with an EC50 of 0.5 μM calcium (Kobayashi and Takamatsu 2009). Studies using hippocalcin−/− mice demonstrated that hippocalcin is involved in approximately 30% of total guanylyl cyclase-mediated signal transduction. Thus, hippocalcin may be involved in the fine-tuning of stimulus detection and odor adaptation mediated by cyclic nucleotide signaling in the olfactory epithelium.
Hippocalcin, Fig. 3

Involvement of hippocalcin in cyclic nucleotide signaling pathways in the olfactory epithelium. G protein guanine nucleotide-binding protein

Interaction Partners

Hippocalcin interacts with MLK (mixed-lineage kinase) 2 (Kobayashi and Takamatsu 2009). Hippocalcin and MLK2 colocalize in the halo surrounding Lewy bodies in patients with Parkinson’s disease (PD) (Nagao and Hayashi 2009). This suggests that both proteins are associated with the pathogenesis of PD; however, the molecular basis has not yet been determined. Hippocalcin also interacts with microsomal cytochrome b5, calmodulin-dependent cyclic nucleotide 3′,5′-phosphodiesterase, CAPS1 (a calcium-dependent activator protein involved in secretion), and the large conductance calcium-activated potassium channel (BK channel). However, the functional consequences of these interactions have not yet been determined (Kobayashi and Takamatsu 2009; Kathiresan et al. 2009).

Associations with Diseases

Using a combination of homozygosity mapping and whole-exome sequencing in a consanguineous kindred affected by autosomal-recessive (AR) isolated dystonia, homozygous mutations in the hippocalcin gene were identified as the cause of an AR primary isolated dystonia. Compound heterozygous mutations of the gene were also identified in a second independent kindred affected by AR isolated dystonia, suggesting a role for perturbed calcium signaling in the pathogenesis of isolated dystonia (Charlesworth et al. 2015).

Hippocalcin levels are increased in human Alzheimer’s disease (AD) brain and in amyloid-β (Aβ) plaque-forming APP23 transgenic mice compared with controls. The primary cultures derived from hippocalcin−/− mice are more susceptible to Aβ toxicity than controls. Aβ treatment induces high levels of toxicity on hippocampal mitochondria from hippocalcin−/− mice already at 3 months of age, indicating a stronger aging phenotype. These data suggest that hippocalcin has a neuroprotective role in AD, presenting it as a putative biomarker (Lim et al. 2012).

A recent report demonstrates that hippocalcin is associated with cancer development. Overexpression of the hippocalcin gene is observed in serrated adenocarcinoma (SAC) and is highly suggestive of SAC diagnosis (sensitivity = 100%) (Conesa-Zamora et al. 2013). This suggests that hippocalcin might be a potential new diagnostic biomarker for SAC; however, the pathological consequence of overexpression of hippocalcin has not yet been determined.

Summary

Hippocalcin, a member of the NCS protein family that is predominantly expressed in the hippocampus, is a highly conserved protein that has an identical amino acid sequence in rat, mouse, bovine, and human. Hippocalcin has three functional EF-hand calcium-binding domains and its N-terminal glycine residue is myristoylated. Hippocalcin is regulated by a calcium myristoyl switch mechanism within cells, allowing it to translocate from the cytosol to intracellular membranes of the trans-Golgi network and to the plasma membrane in response to an increase in free calcium. Synaptic AMPA receptor and NMDA receptor activation produces different spatiotemporal patterns of hippocalcin translocation, indicating that hippocalcin may differentially decode various calcium signaling induced via glutamate receptor activation. Hippocalcin is involved in activity-dependent activation of the MAP kinase pathway via ERK signaling and activation of CREB, key gene expression events mediating the long-lasting synaptic plasticity underlying learning and memory. Spatial and associative learning abilities are impaired in hippocalcin-null mutant (hippocalcin−/−) mice, as determined by the probe test, the Morris water maze, and visual discrimination learning tasks. Hippocalcin is implicated in hippocampal NMDA receptor-dependent LTD via binding to the β2-adaptin subunit of the AP2 adaptor complex, which mediates internalization of the GluR1 subunit of the AMPA receptor. IsAHP, which is activated by brief depolarizations, was not elicited in hippocalcin−/− hippocampal neurons. The decay of sAHP is prolonged in hippocalcin−/− mice. This observation indicates that hippocalcin mediates potassium channel activation in response to calcium influx. Hippocalcin exhibits a protective effect against calcium-induced cell death by interacting with NAIP, diminishing ER stress, and upregulating calcium extrusion. Hippocalcin associates with BB-CK, and together they translocate to membrane compartments in a calcium-dependent manner. Hippocalcin is also expressed in olfactory receptor neurons and regulates the activities of ciliary adenylyl cyclase and particulate guanylyl cyclase in a calcium-dependent manner. Hippocalcin is associated with the pathological processes of several diseases. Homozygous mutations in the hippocalcin gene are the cause of an AR primary isolated dystonia. Aβ treatment induces high levels of toxicity on the primary cultures and hippocampal mitochondria from hippocalcin−/− mice, suggesting that hippocalcin has a neuroprotective role in AD. Overexpression of hippocalcin has been demonstrated in SAC (sensitivity = 100%), providing hippocalcin as a diagnostic biomarker for SAC. Thus, hippocalcin may act as a multifunctional modulator in calcium signaling pathways, such as those underlying neuronal plasticity, neuronal excitability, neuronal cell death, olfaction, and disease progression.

References

  1. Burgoyne RD. Neuronal calcium sensor proteins: generating diversity in neuronal Ca2+ signalling. Nat Rev Neurosci. 2007;8:182–93. doi: 10.1038/nrn2093.PubMedPubMedCentralCrossRefGoogle Scholar
  2. Charlesworth G, Angelova PR, Bartolomé-Robledo F, Ryten M, Trabzuni D, Stamelou M, et al. Mutations in HPCA cause autosomal-recessive primary isolated dystonia. Am J Hum Genet. 2015;96:657–65. doi: 10.1016/j.ajhg.2015.02.007.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Conesa-Zamora P, García-Solano J, García-García F, Turpin Mdel C, Trujillo-Santos J, Torres-Moreno D, et al. Expression profiling shows differential molecular pathways and provides potential new diagnostic biomarkers for colorectal serrated adenocarcinoma. Int J Cancer. 2013;132:297–307. doi: 10.1002/ijc.27674.PubMedCrossRefGoogle Scholar
  4. Dovgan AV, Cherkas VP, Stepanyuk AR, Fitzgerald DJ, Haynes LP, Tepikin AV, Burgoyne RD, Belan PV. Decoding glutamate receptor activation by the Ca2+ sensor protein hippocalcin in rat hippocampal neurons. Eur J Neurosci. 2010;32:347–58. doi: 10.1111/j.1460-9568.2010.07303.x.PubMedPubMedCentralCrossRefGoogle Scholar
  5. Kathiresan T, Harvey M, Orchard S, Sakai Y, Sokolowski B. A protein interaction network for the large conductance Ca(2+)-activated K(+) channel in the mouse cochlea. Mol Cell Proteomics. 2009;8:1972–87. doi: 10.1074/mcp.M800495-MCP200.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Kim KS, Duignan KM, Hawryluk JM, Soh H, Tzingounis AV. The voltage activation of cortical KCNQ channels depends on global PIP2 levels. Biophys J. 2016;110:1089–98. doi: 10.1016/j.bpj.2016.01.006.PubMedPubMedCentralCrossRefGoogle Scholar
  7. Kobayashi M, Takamatsu K. Hippocalcin. UCSD-Nature Molecule Pages. 2009; doi: 10.1038/mp.a004097.01.Google Scholar
  8. Kobayashi M, Takamatsu K, Saitoh S, Miura M, Noguchi T. Molecular cloning of hippocalcin, a novel calcium-binding protein of the recoverin family exclusively expressed in hippocampus. Biochem Biophys Res Commun. 1992;189:511–7. doi: 10.1016/0006-291X(92)91587-G.PubMedCrossRefGoogle Scholar
  9. Kobayashi M, Masaki T, Hori K, Masuo Y, Miyamoto M, Tsubokawa H, et al. Hippocalcin-deficient mice display a defect in cAMP response element-binding protein activation associated with impaired spatial and associative memory. Neuroscience. 2005;133:471–84. doi: 10.1016/j.neuroscience.2005.02.034.PubMedCrossRefGoogle Scholar
  10. Kobayashi M, Hamanoue M, Masaki T, Furuta Y, Takamatsu K. Hippocalcin mediates calcium-dependent translocation of brain-type creatine kinase (BB-CK) in hippocampal neurons. Biochem Biophys Res Commun. 2012;429(3–4):142–7. doi: 10.1016/j.bbrc.2012.10.125.PubMedCrossRefGoogle Scholar
  11. Li C, Ames JB. 1H, 13C, and 15N chemical shift assignments of neuronal calcium sensor protein, hippocalcin. Biomol NMR Assign. 2014;8:63–6. doi: 10.1007/s12104-012-9453-3.PubMedCrossRefGoogle Scholar
  12. Lim YA, Giese M, Shepherd C, Halliday G, Kobayashi M, Takamatsu K, et al. Role of hippocalcin in mediating Aβ toxicity. Biochim Biophys Acta. 2012;1822:1247–57. doi: 10.1016/j.bbadis.2012.04.007.PubMedCrossRefGoogle Scholar
  13. Lindholm D, Mercer EA, Yu LY, Chen Y, Kukkonen J, Korhonen L, et al. Neuronal apoptosis inhibitory protein: structural requirements for hippocalcin binding and effects on survival of NGF-dependent sympathetic neurons. Biochim Biophys Acta. 2002;1600:138–47. doi: 10.1016/S1570-9639(02)00454-5.PubMedCrossRefGoogle Scholar
  14. Mammen A, Simpson PJ, Mamman A, Simpson JP, Nighorn A, Imanishi Y, et al. Hippocalcin in the olfactory epithelium: a mediator of second messenger signaling. Biochem Biophys Res Commun. 2004;322:1131–9. doi: 10.1016/j.bbrc.2004.07.123.PubMedCrossRefGoogle Scholar
  15. Markova O, Fitzgerald D, Stepanyuk A, Dovgan A, Cherkas V, Tepikin A, et al. Hippocalcin signaling via site-specific translocation in hippocampal neurons. Neurosci Lett. 2008;442:152–7. doi: 10.1016/j.neulet.2008.06.089.PubMedPubMedCentralCrossRefGoogle Scholar
  16. Nagao M, Hayashi H. Mixed lineage kinase 2 and hippocalcin are colocalized in Lewy bodies of Parkinson’s disease. J Neurol Sci. 2009;281:51–4. doi: 10.1111/j.1471–4159.2009.06344.x.PubMedCrossRefGoogle Scholar
  17. O’Callaghan DW, Haynes LP, Burgoyne RD. High-affinity interaction of the N-terminal myristoylation motif of the neuronal calcium sensor protein hippocalcin with phosphatidylinositol 4,5-bisphosphate. Biochem J. 2005;391:231–8. doi: 10.1042/BJ20051001.PubMedPubMedCentralCrossRefGoogle Scholar
  18. Oh DY, Yon C, Oh KJ, Lee KS, Han JS. Hippocalcin increases phospholipase D2 expression through extracellular signal-regulated kinase activation and lysophosphatidic acid potentiates the hippocalcin-induced phospholipase D2 expression. J Cell Biochem. 2006;97:1052–65. doi: 10.1002/jcb.20665.PubMedCrossRefGoogle Scholar
  19. Palmer CL, Lim W, Hastie PG, Toward M, Korolchuk VI, Burbidge SA, et al. Hippocalcin functions as a calcium sensor in hippocampal LTD. Neuron. 2005;47:487–94. doi: 10.1016/j.neuron.2005.06.014.PubMedPubMedCentralCrossRefGoogle Scholar
  20. Tzingounis AV, Kobayashi M, Takamatsu K, Nicoll RA. Hippocalcin gates the calcium activation of the slow afterhyperpolarization in hippocampal pyramidal cells. Neuron. 2007;53:487–93. doi: 10.1016/j.neuron.2007.01.011.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of PhysiologyToho University School of MedicineTokyoJapan